by adminTorusBrand | Jan 27, 2017 | Axim Biotechnologies, Company News, HempMeds Brasil, HempMeds Mexico, Media Coverage
Dr. Stuart Titus sat down with Everett Jolly of Uptick Newswire this week to discuss the ever increasing momentum driving marijuana legalization and the growth of the cannabis industry. Dr. Titus began the interview relaying recent accomplishments by Medical...
by adminTorusBrand | Jan 24, 2017 | Company News, HempMeds Mexico, Scientific Research
Cancer patient in Mexico receives approval for RSHO-X™ to treat pain associated with cancer treatments and promote general well-being. HempMeds® Mexico, a subsidiary of Medical Marijuana, Inc., announced this week that their flagship product RSHO-X™ received approval...
by adminTorusBrand | Jan 23, 2017 | Company News, HempMeds Mexico, Media Coverage
[vc_row][vc_column][vc_column_text] In an interview with the International Business Times, Dr. Stuart Titus revealed how THC-free RSHO™ helped spark cannabis reform in Mexico and what the next steps are for the worldwide cannabis industry. A comprehensive article...
by adminTorusBrand | Jan 18, 2017 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies Brings Their Patented CanChew® Plus Delayed-Release CBD Chewing Gum to Clinical Trials for IBS, a $1.5B market opportunity. AXIM® Biotechnologies announced this week that the company has entered clinical trials...
by adminTorusBrand | Jan 10, 2017 | Company News, HempMeds Brasil
Medical Marijuana, Inc. and its subsidiary HempMeds® Brasil announced late last week that the company has signed into a distribution partnership with Paragon HealthCare BR, a leading global wholesale distributor of pharmaceutical products. This is just the latest of...
by adminTorusBrand | Jan 6, 2017 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text] High Times Magazine features Medical Marijuana, Inc. and AXIM® Biotechnologies in article titled “10 Largest Marijuana Companies Raking in Huge Profits”. Both Medical Marijuana, Inc. and AXIM® Biotechnologies received validation of...